Patricia Zilliox's guest appearances

Patricia Zilliox

Medsider: Learn from MedTech and HealthTech Experts

Innovate Fort Worth

Medical Device Success - Your Success is Our Mission!

Mastering Medical Device

Laura Yecies

Brian Dixon

Derek Herrera

Steve Anderson

Scott Carson

Scott Anderson

David Nelson

John Simpson

Dylan Jones

Scott Wolf

John Murphy

Bob Beck

Mike Berry

Dan Rose

Jonathan Morris

OwlTail

In this episode of Medsider Radio, we’re sitting down with Patricia Zilliox, who has spent her entire career working in ophthalmology, including 30 years at American-Swiss medical company Alcon. In 2017, Patricia became CEO of Eyevensys, a biotech company in the clinical stage of making a drug delivery system to fight various eye diseases. In this interview, Patricia gives advice for navigating the complicated world of regulatory affairs, the dos and don’ts of planning clinical trials, and why raising capital is the most frustrating part of her job.Before we jump into the conversation, I wanted to mention a few things:If you’re into learning from proven medtech and healthtech leaders, and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content. Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced healthcare leaders about the nuts and bolts of running a business and bringing products to market. This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.In addition to the entire back catalog of Medsider interviews over the past decade, Premium members get exclusive Ask Me Anything interviews and masterclasses with some of the world’s most successful medtech founders and executives. Since making the premium memberships available, I’ve been pleasantly surprised at how many people have signed up. If you’re interested, go to medsider.com/subscribe to learn more.Lastly, here's the link to the full interview with Patricia if you'd rather read it instead.

In this episode of <a href="https://medsider.com/news" rel="nofollow" target="_blank">Medsider Radio</a>, we’re sitting down with <a href="https://www.linkedin.com/in/patricia-zilliox-b433671/" rel="nofollow" target="_blank">Patricia Zilliox</a>, who has spent her entire career working in ophthalmology, including 30 years at American-Swiss medical company <a href="https://www.alcon.com/" rel="nofollow" target="_blank">Alcon</a>. In 2017, Patricia became CEO of <a href="https://www.eyevensys.com/" rel="nofollow" target="_blank">Eyevensys</a>, a biotech company in the clinical stage of making a drug delivery system to fight various eye diseases. In this interview, Patricia gives advice for navigating the complicated world of regulatory affairs, the dos and don’ts of planning clinical trials, and why raising capital is the most frustrating part of her job.Before we jump into the conversation, I wanted to mention a few things:If you’re into learning from proven medtech and healthtech leaders, and want to know when new content and interviews go live, head over to <a href="https://medsider.com/" rel="nofollow" target="_blank">Medsider.com</a> and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content. Second, if you want even more inside info from proven experts, think about a <a href="https://medsider.com/subscribe" rel="nofollow" target="_blank">Medsider premium membership</a>. We talk to experienced healthcare leaders about the nuts and bolts of running a business and bringing products to market. This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.In addition to the entire back catalog of Medsider interviews over the past decade, Premium members get exclusive Ask Me Anything interviews and masterclasses with some of the world’s most successful medtech founders and executives. Since making the premium memberships available, I’ve been pleasantly surprised at how many people have signed up. If you’re interested, go to <a href="https://medsider.com/subscribe" rel="nofollow" target="_blank">medsider.com/subscribe</a> to learn more.Lastly, here's the <a href="http://medsider.com/patricia-zilliox-eyevensys" rel="nofollow" target="_blank">link to the full interview</a> with Patricia if you'd rather read it instead.

How to Navigate Clinical Trials and Fundraising Challenges: Interview with Eyevensys CEO Patricia Zilliox

Patricia Zilliox has devoted her career to solving problems with the eyes. She had a very successful career at Alcon, then at the Foundation Fighting Blindness Clinical Research Institute, before joining Eyevensys as CEO.  Eyevensys is working on a technology that has the potential to solve a big problem. In this episode Patricia shares how a biologics company approaches device design and manufacture, combination product development, the regulatory pathway, funding challenges, how device differs but is similar to pharma and biologics, and how great companies retain great people. Links from this episode:Patricia Zilliox, PhD LinkedInEyevensysMastering Medical Device:WebsitePat Kothe LinkedIn

Patricia Zilliox has devoted her career to solving problems with the eyes. She had a very successful career at Alcon, then at the Foundation Fighting Blindness Clinical Research Institute, before joining Eyevensys as CEO.  Eyevensys is working on a technology that has the potential to solve a big problem. In this episode Patricia shares how a biologics company approaches device design and manufacture, combination product development, the regulatory pathway, funding challenges, how device differs but is similar to pharma and biologics, and how great companies retain great people.  Links from this episode:<ul><li><a href="https://www.linkedin.com/in/patricia-zilliox-b433671/" rel="nofollow" target="_blank">Patricia Zilliox, PhD LinkedIn</a></li><li><a href="https://www.eyevensys.com" rel="nofollow" target="_blank">Eyevensys</a></li></ul> Mastering Medical Device:<ul><li><a href="https://www.masteringmedicaldevice.com/" rel="nofollow" target="_blank">Website</a></li><li><a href="http://www.linkedin.com/in/patrick-kothe" rel="nofollow" target="_blank">Pat Kothe LinkedIn</a></li></ul>

Why a Device and Biologic Combination Product is a Challenge and an Opportunity with Patricia Zilliox 

Patricia Zilliox could have chosen any city as U.S. headquarters for her French biotech startup Eyevensys, which recently raised $30 million to develop eye disease treatments. She chose Fort Worth. That’s because Alcon and the North Texas Eye Research Institute at HSC have turned Cowtown into a world-renowned hotbed of eye research innovation. Learn more:   North Texas Eye Research Institute Eyevensys  The (Alcon) Family Tree: How One Company Seeded a DFW Life Science Legacy

Patricia Zilliox could have chosen any city as U.S. headquarters for her French biotech startup Eyevensys, which recently raised $30 million to develop eye disease treatments. She chose Fort Worth. That’s because Alcon and the North Texas Eye Research Institute at HSC have turned Cowtown into a world-renowned hotbed of eye research innovation. Learn more:  <a href="https://www.unthsc.edu/north-texas-eye-research-institute/" rel="nofollow" target="_blank"> North Texas Eye Research Institute</a> <a href="http://www.eyevensys.com/" rel="nofollow" target="_blank">Eyevensys</a> <a href="https://dallasinnovates.com/the-alcon-family-tree-how-one-companys-roots-led-to-a-dfw-life-science-legacy/" rel="nofollow" target="_blank"> The (Alcon) Family Tree: How One Company Seeded a DFW Life Science Legacy</a>

#7 Patricia Zilliox: An Eye for Innovation